Loading...
XASE
KNW
Market cap22mUSD
Jun 10, Last price  
2.99USD
Name

Know Labs Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
7.77%
Rev. gr., 5y
-48.31%
Revenues
0k
000002,542,6279,136,2167,923,9768,572,7997,983,3526,290,7946,023,6004,874,3594,303,2961,804,960121,93904,360,08700
Net income
-17m
L-18.89%
-868,643-1,032,036-1,634,993-945,066-950,609-1,148,920-2,409,756-2,731,898-6,621,894-1,017,281-2,631,037-1,746,495-3,901,232-3,257,597-7,612,316-13,562,641-25,360,213-27,568,414-20,443,050-16,582,000
CFO
-13m
L+23.91%
-788,514-770,493-317,4541645,120-440,968-1,312,291-58,174-3,503,580-1,379,397-239,877-3,373,734-1,264,324-1,117,131-3,104,035-3,913,803-6,850,699-6,919,808-10,353,991-12,829,350

Profile

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
IPO date
Apr 12, 2006
Employees
15
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
15,494
14,042
Unusual Expense (Income)
NOPBT
(15,494)
(14,042)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(15,494)
(14,042)
Net income
(16,582)
-18.89%
(20,443)
-25.85%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,193
5,473
BB yield
-69.09%
-44.15%
Debt
Debt current
4,425
2,917
Long-term debt
1,016
155
Deferred revenue
Other long-term liabilities
Net debt
2,329
(4,952)
Cash flow
Cash from operating activities
(12,829)
(10,354)
CAPEX
(66)
(81)
Cash from investing activities
(66)
(81)
Cash from financing activities
7,983
5,865
FCF
(15,672)
(13,117)
Balance
Cash
3,111
8,024
Long term investments
Excess cash
3,111
8,024
Stockholders' equity
(138,625)
(121,758)
Invested Capital
141,551
128,418
ROIC
ROCE
EV
Common stock shares outstanding
26,246
49,581
Price
0.29
14.56%
0.25
-86.34%
Market cap
7,517
-39.36%
12,395
-83.22%
EV
9,849
7,446
EBITDA
(15,224)
(13,586)
EV/EBITDA
Interest
1,513
262
Interest/NOPBT